Trials / Sponsors / Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis Osteopenia | Phase 2 | 2011-01-01 |
| Completed | A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women Osteoporosis, Postmenopausal | Phase 3 | 2009-06-01 |
| Completed | A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women Phase 1 Pharmacodynamic Study | Phase 2 | 2008-12-01 |
| Completed | A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women Osteoporosis | Phase 2 | 2008-02-01 |